The potency of essential nutrient taurine on boosting the antioxidant status and chemopreventive effect against benzo (a)pyrene induced experimental lung cancer

Biomedicine and Preventive Nutrition

Volumn 4, Issue 2, 2014, Pages 251-255

  Venkatachalam, Sivabalan ^a   Kuppusamy, Periyyasamy ^a   Kuppusamy, Baskaran ^a   Dhanapal, Sakthisekaran ^a  

^a UNIVERSITY OF MADRAS   (India)

Author keywords

Antioxidant; Benzo (a)pyrene; CEA; LPO; Taurine

Indexed keywords

BENZO[A]PYRENE; CARBONYL DERIVATIVE; CARCINOEMBRYONIC ANTIGEN; LIPID PEROXIDE; REACTIVE OXYGEN METABOLITE; TAURINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTINEOPLASTIC ACTIVITY; ANTIOXIDANT ACTIVITY; ARTICLE; BODY WEIGHT; CHEMOPROPHYLAXIS; CONTROLLED STUDY; DRUG EFFECT; DRUG POTENCY; LIPID PEROXIDATION; LUNG CANCER; LUNG CARCINOGENESIS; LUNG WEIGHT; MALE; MOUSE; NONHUMAN; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROTEIN SYNTHESIS; TREATMENT DURATION;

MUS;

EID: 84901626371     PISSN: 22105239     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bionut.2013.09.006     Document Type: Article

References (43)

1. Ferlay J, Shin HR, Bray F, Forman D, Mathers C, Parkin DM. GLOBOCAN 2008V.2.0: cancer incidence and mortality worldwide, IARC Cancer Base, no. 10.
2. Hecht S.S., Upadhyaya P., Wang M., Bliss R.L., McIntee E.J., Kenney P.M. Inhibition of lung tumorigenesis in A/J mice by N-acetyl-S- (N-2-phenethylthiocarbamoyl)-L-cysteine and myo-inositol, individually and in combination. Carcinogenesis 2002, 23:1455-1461.
3. Sticha K.R., Staretz M.E., Wang M., Liang H., Kenney P.M., Hecht S.S. Effects of benzyl isothiocyanate and phenethyl isothiocyanate on benzo[a]pyrene metabolism and DNA adduct formation in the A/J mouse. Carcinogenesis 2000, 211:711-1719.
4. Wattenberg L.W. Chemoprevention of cancer. Cancer Res 1985, 45:1-8.
5. Havsteen B.H. The biochemistry and medical significance of the flavonoids. Pharmacol Ther 2002, 96:67-202.
6. Boucknooghe T., Remacle C., Reusens B. Is taurine a functional nutrient?. Curr Opin Clin Nutr Metab Care 2006, 9:728-733.
7. Wright C.E., Tallan H.H., Lin Y.Y., Gaull G.E. Taurine: biological update. Ann Rev Biochem 1986, 55:427-453.
8. Wright C.E., Lin T.T., Syurman J.A., Gaull G.E. Taurine scavenges oxidized chlorine in biological systems. Prog Clin Biol Res 1985, 179:137-147.
9. Huxtable R.J. Physiological actions of taurine. Physiol Rev 1992, 72:101-163.
10. Lowry O.H., Rusebrough N.J., Farr A.L., Randall R.J. Protein measurement with folin-phenol reagent. J Biol Chem 1951, 193:265-275.
11. Marklund S., Marklund G. Involvement of superoxide anion radical in the autoxidation of pyrogallol and a convenient assay for superoxide dismutase. Eur J Biochem 1974, 47:469-474.
12. Sinha A.K. Colorimetric assay of catalase. Anal Biochem 1972, 47:389-394.
13. Rotruck J.T., Pope A.L., Ganther H.E., Swanson A.B., Hafeman D.G., Hoekstra W.G. Selenium: biochemical role as a component of glutathione peroxidase purification and assay. Science 1973, 179:588-590.
14. Stahl G.E.J., Visser J., Veeger C. Purification and properties of glutathione reducatse of human erythrocytes. Biochim Biophys Acta 1969, 185:39-48.
15. Moron M.S., DePierre J.W., Manerwik K.B. Levels of glutathione, glutathionereductase and glutathione-S-transferase activities in rat lung and liver. Biochim Biophys Acta 1979, 582:67-68.
16. Desai I.D. Vitamin E analysis methods for animal tissues. Methods Enzymol 1984, 105:138-147.
17. Omaye S.T., Turabull J.D., Sauberlich H.E. Selected methods for the determination of ascorbic acid in animal cells, tissues and fluids. Methods Enzymol 1979, 62:1-11.
18. Uchiyama M., Mihara M. Determination of malonaldehyde precursor in tissues by thiobarbituric acid test. Anal Biochem 1978, 86:271-278.
19. Levins R.L., Garland D., Oliver C.N., Amici A., Lenz A.G., Alon W., et al. Determination of carbonyl contents in oxidative modified proteins. Methods Enzymol 1990, 186:464-478.
20. Mayne S.T. Antioxidant nutrients and chronic disease: use of biomarkers of exposure and oxidative stress status in epidemiologic research [J]. J Nutr 2003, 133:933S-940S.
21. Bagchi K., Puri S. Free radicals and antioxidants in health and disease [J]. East Mediterr Health J 1998, 4:350-360.
22. Cugell D.W., Kamp D.W. Asbestos and the pleura: a review. Chest 2004, 125:1103-1117.
23. Kim S.H., Kwack S.J., Lee B.M. Lipid peroxidation, antioxidant enzymes, and benzo[a]pyrene-quinones in the blood of rats treated with benzo[a]pyrene. Chem Biol Interact 2000, 127:139-150.
24. Kundu J.K., Surh Y.J. Inflammation: gearing the journey to cancer. Mutat Res 2008, 659:15-30.
25. Chesney R.W. Taurine: its biological role and clinical implications. Adv Pediatr 1985, 32:1-42.
26. Redmond H.P., Wang J.H., Bouchier-Hayes D. Taurine attenuates nitric oxide- and reactive oxygen intermediate-dependent hepatocyte injury. Arch Surg 1996, 131:1280-1287.
27. Schuller-Levis G.B., Park E. Taurine and its chloramine: modulators of immunity. Neurochem Res 2004, 29(1):117-126.
28. Thompson J.A., Grunert F., Zimmennann W. Carcinoembryonic antigen gene family: molecular biology and clinical perspectives. J Clin Lab Anal 1991, 5:344-366.
29. Emre M.H., Aktay G., Polat A., Vardt N. Effects of benzo(a)pyrene and ethanol on oxidative stress of brain, lung tissues and lung morphology in rats. Chin J Physiol 2007, 50:143-148.
30. Ekambaram G., Rajendran P., Magesh V., Sakthisekaran D. Naringenin reduces tumor size and weight lost in N-methyl-N'-nitro-N-nitrosoguanidine-induced gastric carcinogenesis in rats. Nutr Res 2008, 28:106-112.
31. Van Driel B.E., Lyon H., Hoogenraad D.C., Anten S., Hansen U., Van Noorden C.J. Expression of CuZn- and Mn-superoxide dismutase in human colorectal neoplasms. Free Radic Biol Med 1997, 23:435-444.
32. Selvendiran K., Singh J.P., Krishnan K.B., Sakthisekaran D. Cytoprotective effect of piperine against benzo[a]pyrene induced lung cancer with reference to lipid peroxidation and antioxidant system in Swiss albino mice. Fitoterapia 2003, 74:109-115.
33. Kamaraj S., Vinodhkumar R., Anandakumar P., Jagan S., Ramakrishnan G., Devaki T. The effects of quercetin on antioxidant status and tumor markers in the lung and serum of mice treated with benzo(a) pyrene. Biol Pharm Bull 2007, 30:2268-2273.
34. Hanna J., Chahine R., Aftimos G., Nader M., Mounayar A., Esseily F., et al. Protective effect of taurine against free radicals damage in the rat myocardium. Exp Toxicol Pathol 2004, 56:189-194.
35. Haque R., Bin-Hafeez B., Parvez S., et al. Aqueous extract of walnut (Juglans regia L.) protects mice against cyclophosphamide-induced biochemical toxicity. Hum Exp Toxicol 2003, 22:473-480.
36. Palomero J., Galan A.I., Munoz M.E., Tunon M.J., Gonzalez-Gallego J., Jimenez R. Effects of aging on the susceptibility to the toxic effects of cyclosporine A in rats. Changes in liver glutathione and antioxidant enzymes. Free Radic Biol Med 2001, 30:836-845.
37. Magesh V., Durgabhavani K., Rajendran P., Ekambaram G., Sakthisekaran D. Reduction of mitochondrial oxidative damage and improved mitochondrial efficiency by administration of crocetin against benzo[a]pyrene induced experimental animals. Biol Pharm Bull 2008, 31(9):1639-1645.
38. Joydeep Das, Jyotirmoy Ghosh, Prasenjit Manna, Parames C. Sil mail. Protective role of taurine against arsenic-induced mitochondria-dependent hepatic apoptosis via the inhibition of PKCδ-JNK pathway. Plosone 2010, 5(9):1-19.
39. Adly A.M. Oxidative stress and disease: an updated review. Res J Immunol 2010, 3:129-145.
40. Parvez S., Tabassum H., Banerjee B.D., Raisuddin S. Taurine prevents tamoxifen-induced mitochondrial oxidative damage in mice. Basic Clin Pharmacol Toxicol 2008, 102(4):382-387.
41. You J.S., Chang K.J. Taurine protects the liver against lipid peroxidation and membrane disintegration during rat hepatocarcinogenesis. Adv Exp Med Biol 1998, 442:105-112.
42. Stadtman E.R., Berlett B.S. Reactive oxygen-mediated protein oxidation in aging and disease. Drug Metab Rev 1998, 30:225-243.
43. Beal M.F. Oxidatively modified proteins in aging and disease. Free Radic Biol Med 2002, 32:797-803.